Journal of General Virology · 2017 · 10 citations · 27 references
Life SciencesBiotechnologyInfectious DiseasesGene DeliveryMolecular VirologyVirologyVector ProductionVector-pathogen InteractionsViral InfectionsViral PathogenesisViral TropismViral Vector-mediated TransgenesisGene-targeted TherapyRecombinant Expression SystemsSingle-chain Variable FragmentsViral Expression VectorsViral Genome EngineeringViral Vector DeliveryViral Vector TransgenesisViral Vectors
Viruses from the diverse family of Paramyxoviridae include important pathogens and are applied in gene therapy and for cancer treatment. The Tupaia paramyxovirus (TPMV), isolated from the kidney of a tree shrew, does not infect human cells and neutralizing antibodies against other Paramyxoviridae do not cross-react with TPMV. Here, we present a vector system for de novo generation of infectious TPMV that allows for insertion of additional genes as well as targeting using antibody single-chain variable fragments. We show that the recombinant TPMV specifically infect cells expressing the targeted receptor and replicate in human cells. This vector system provides a valuable tool for both basic research and therapeutic applications.
27
Bats host major mammalian paramyxoviruses
Jan Felix Drexler, Victor M. Corman, Marcel A. Müller et al. · Nature Communications · 2012 · 700 citations · Full text
Rescue of measles viruses from cloned DNA.
Frank Radecke, Pius Spielhofer, Henriette Schneider et al. · The EMBO Journal · 1995 · 637 citations · Full text
CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy
Christine E. Engeland, Christian Grossardt, Rūta Veinalde et al. · Molecular Therapy · 2014 · 283 citations · Full text
Medicine, Immunology, Oncology +17